Crispr Therapeutics Ag (CRSP)

R&D Expenses

$270.29M

TTM · Period ending: · USD

CRSP logo

CRSP R&D Expenses

Latest reported$270.29M
CRSP TTM R&D Expenses ($12.57M → $270.29M)
High-resolution chart · PNG

CRSP r&d expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Crispr Therapeutics Ag R&D Expenses — Trailing twelve months (TTM) (USD)
Period endingR&D Expenses (USD)
270,293,000
270,635,000
274,545,000
278,835,000
297,293,000
307,319,000
306,174,000
319,163,000
332,501,000
358,736,000
387,332,000
395,743,000
421,667,000
443,335,000
461,645,000
461,185,000
428,063,000
387,172,000
339,547,000
318,817,000
306,325,000
283,373,000
266,946,000
233,342,000
219,580,000
199,733,000
179,362,000
159,402,000
141,976,000
128,076,000
113,773,000
105,002,000
83,027,000
74,514,000
69,800,000
65,342,000
59,549,000
51,031,000
42,238,000
32,840,000
24,537,000
17,421,000
12,573,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.